Who We Are

Built on 80 years of experience, SK pharmteco is a trusted partner specializing in the manufacture of APIs and intermediates, viral vectors for gene and cell therapies, registered starting materials and analytical services for the pharmaceutical industry worldwide. Our global operations have the capability and capacity to support your needs from development through commercial production.

Our complementary assets and expertise enable us to provide the highest quality services to our customers.

SK pharmteco's SmartPlatform Portfolio

An integrated solution for every CDMO process 

Our Services

SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, Key Building Blocks and Viral Vectors. Our offerings include process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production. Additionally, we offer extensive Adeno-Associated Viral (AAV) and Lentiviral vector development and cGMP production capabilities.

Our global operations include 6 cGMP manufacturing and development facilities across the United States, Korea, Ireland and France. We also operate a dedicated analytical services facility.

SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:

We provide PAI and full regulatory support as well as complete confidentiality. We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea). 

With a strong technology toolbox and ~1,000 m³ (~265,000 gal) of global small-molecule capacity plus a 5,000 m² facility dedicated to large molecules, we have the capability and capacity to support your needs across the full lifecycle.

The most trusted global partner in the delivery of innovative medicine

We are committed to changing the world through our unwavering dedication to life-saving therapies.
We enable our partners with cutting-edge technology, expertise and customer centricity, allowing them to bring breakthrough treatments to patients and delivering happiness and health to stakeholders everywhere.

Global Presence


6 Manufacturing Sites

~1,000 m³ (~265,000 gal) 
Small Molecule Production Capacity
3 US (589 m³), 2 Korea (276 m³), 1 Ireland (97 m³)
5,000 m² Facility for
Large Molecule Manufacturing
1 France (expanding to 10,000 m²)

4 R&D Centers

US, Ireland, France, Korea

1 Analytical
Services Facility

Years of Experience 1

80 Years of Experience


1,600+ Highly Skilled and Talented Workforce

Highly Skilled and Talented Workforce 1

approved by global regulatory agencies



Diazomethane, Azide, Hydrazine, Ozone

Fixed bed, CSTR, PAT

Simulated Moving Bed (SMB), Batch

Up to 4 m(~1,000 gal) scale 

Down to 10 ng/mcontainment 

Schedule II-V Manufacturing  

Schedule I By Request

Crystallization, Micronization 

Our Team

Play Video


Contact Us

For Business Development & Marketing Enquires contact
Scroll to Top

Enter your details to access Marketing Materials